Filter
263
Text search:
pharmacotherapy
Featured
Recommendations
20
New Publications
42
Language
Document type
No document type
153
Guidelines
47
Studies & Reports
39
Manuals
11
Strategic & Response Plan
5
Training Material
4
Fact sheets
3
Resource Platforms
1
Countries / Regions
India
19
Global
10
Western and Central Europe
8
Ethiopia
7
South Africa
7
Latin America and the Carribbean
7
Kenya
6
Eastern Europe
6
Indonesia
4
Chile
4
Uganda
3
Rwanda
3
Ukraine
3
Africa
3
Russia
3
Sierra Leone
2
Nigeria
2
Philippines
2
Malawi
2
Brazil
2
Paraguay
2
Estonia
2
Liberia
1
USA
1
South Sudan
1
Germany
1
Chad
1
Cambodia
1
Eswatini/ Swaziland
1
North Macedonia
1
Botswana
1
Mexico
1
Myanmar / Burma
1
South–East Asia Region
1
Other region
1
Asia
1
Canada
1
Jamaica
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
63
Public Health
27
Clinical Guidelines
27
Women & Child Health
6
Key Resources
4
Capacity Building
2
Pharmacy & Technologies
2
Toolboxes
Mental Health
104
NCDs
33
Pharmacy
22
HIV
14
NTDs
7
TB
5
AMR
4
Ebola & Marburg
2
Refugee
2
COVID-19
2
Caregiver
2
Malaria
2
Global Health Education
1
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f
...
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
Злоупотребление алкоголем и алкоголизм относятся к ведущим причинам ухудшения здоровья и повышения смертности населения. Чрезмерное употребление алкоголя служи
...
The WHO Global Burden of Disease (GBD) study measures the burden of
disease using the disability-adjusted life year metric (DALY). The DALY metric
was developed to assess the burden of disease consistently across diseases,
risk factors and regions. A consistent and comparative description of the
...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
This Review summarizes many of the persistent biological alterations associated with childhood maltreatment including changes in neuroendocrine and neurotransmitter systems and pro-inflammatory cytokines in addition to specific alterations in brain areas associated with mood regulation. Finally, I d
...
Journal of Child Psychology and Psychiatry60:5 (2019), pp 500–515
Resources for the Prevention and Treatment of Substance Use Disorders (SUD)
Q8: What is the effectiveness, safety and role of pharmacological interventions, by non-specialized health care providers, for the broad category of Disruptive Behaviour Disorders (DBDs), Conduct Disorder (CD), Oppositional Defiant Disorder (ODD) and comorbid (but not exclusively) Attention-Deficit
...
Lancet Psychiatry 2016;3: 415–24
Depress Anxiety. 2018 March ; 35(3): 195–208. doi:10.1002/da.22711.
Indian J Psychiatry. 2017 Jan; 59(Suppl 1): S67–S73.
doi: 10.4103/0019-5545.196975: 10.4103/0019-5545.196975
Отчет оценочной
миссии
Январь 2014 г
An Evidence-Based Treatment Guide for Clinicians
Introduction
Chapter A.7
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Биполярное расстройство в детском возрасте
Клинический случай
Post-Traumatic Stress Disorder (PTSD) in Children under Age 6 | Post-Traumatic Stress Disorder (PTSD) in Children and Adolescents Ages 6 to 17 Years Old
